CSC Wins $19.7 Million Award for Advanced Development of Biodefense Vaccines
EL SEGUNDO, Calif. -- Computer Sciences Corporation (CSC) announced that DVC LLC, a CSC company, has been awarded approximately $19.7 million in grants and contract modifications from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health.
The new grants and contract modifications are in addition to the award of an $11 million grant to CSC from the NIAID in September 2003.
Under the terms of these new awards, DVC will continue the advanced development of vaccines for tularemia, botulism and Venezuelan equine encephalitis. The company will perform stability testing and manufacture a current good manufacturing practices pilot batch of live tularemia vaccine. DVC also will conduct a phase 2 clinical trial for its Venezuelan equine encephalitis vaccine candidate and continue development of a stable multivalent botulinum vaccine candidate.
NIAID is a component of the National Institutes of Health, an agency of the U.S. Department of Health and Human Services. NIAID conducts and supports research that strives to understand, treat and ultimately prevent the myriad of infectious, immunologic and allergic diseases that threaten hundreds of millions of people worldwide.
DVC is a biopharmaceutical company dedicated to the development and licensure of safe and efficacious biodefense vaccines and therapeutics. DVC is part of CSCs Enforcement, Security and Intelligence organization, which CSC created in 2002 to support programs enhancing U.S. security.
Source: Computer Sciences Corporation
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
